Publikationer pr. år
Publikationer pr. år
Personlig profil
Expertise
Lung cancer; Neuroendocrine tumors; Bronchopulmonary neuroendocrine tumors; Malignant mesotheliomas; Extravasation of chemotherapy; Exercise intervention in cancer patients; Predictive and prognostic markers in cancer, Clinical nuclear imaging in oncology; Anti cancer drug development.
Primære forskningsområder
Clinical phase 2 and 3 therapeutic trials in lung cancer and neuroendocrine carcinomas; Pre- and postoperative excercise intervention studies in lung cancer; Epidemiological, demographic, clinical and translational studies of neuroendocrine carcinomas and bronchopulmonary neuroendocrine tumors; Early response evaluation in lung cancer and neuroendocrine tumors by different nuclear imaging (PET-) tracers and molecular markers; Translational studies of extravastion of chemotherapy.
Aktuel forskning
Clinical phase 2 and 3 therapeutic trials in lung cancer and neuroendocrine carcinomas; Pre- and postoperative excercise intervention studies in lung cancer; Epidemiological, demographic, clinical and translational studies of neuroendocrine carcinomas and bronchopulmonary neuroendocrine tumors; Early response evaluation in lung cancer and neuroendocrine tumors by nuclear imaging (PET-) tracers and molecular markers. Prognostic and predictive value of immunomarkers in lung cancer
Mulige interessekonflikter
None
Eksterne ansættelser
Klinisk lektor, Institut for Klinisk Medicin, Københavns Universitet
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Seppo Wang Langer er aktive. Disse emneetiketter kommer fra denne persons arbejder. Sammen danner de et unikt fingerprint.
- 1 Lignende profiler
Samarbejde og topforskningsområder i de sidste fem år
Seneste eksterne samarbejde på lande-/områdeniveau. Dyk ned i detaljerne ved at klikke på prikkerne eller
Publikation
-
Appendiceal Neuroendocrine Neoplasms: an Update for 2023
Holmager, P., Langer, S. W., Kjaer, A., Ringholm, L., Garbyal, R. S., Hansen, C. P., Andreassen, M. & Knigge, U., feb. 2024, I: Current Oncology Reports. 26, 2, s. 114-120 7 s.Publikation: Bidrag til tidsskrift › Review › peer review
2 Citationer (Scopus) -
Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with 177Lu/225AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas
Perrone, E., Ghai, K., Eismant, A., Andreassen, M., Langer, S. W., Knigge, U., Kjaer, A. & Baum, R. P., 26 apr. 2024, I: Diagnostics. 14, 9, 907.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
NETest in advanced high-grade gastroenteropancreatic neuroendocrine neoplasms
Sorbye, H., Hjortland, G. O., Vestermark, L. W., Sundlov, A., Assmus, J., Couvelard, A., Perren, A. & Langer, S. W., 27 jun. 2024, (E-pub ahead of print) I: Journal of Neuroendocrinology. s. e13428Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced Disease
Slott, C., Langer, S. W., Møller, S., Krogh, J., Klose, M., Hansen, C. P., Kjaer, A., Holmager, P., Garbyal, R. S., Knigge, U. & Andreassen, M., 1 jan. 2024, I: Cancers. 16, 1, 204.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
Prognostic thresholds of fluorine-18 fluorodeoxyglucose-positron emission tomography mean and maximum standardized uptake values for survival and nodal involvement in lung neuroendocrine neoplasms
Soldath, P., Binderup, T., Kjaer, A., Knigge, U., Langer, S. W. & Petersen, R. H., 1 feb. 2024, I: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 65, 2, ezae030.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review